Jonathan P. Sleeman

16.4k citations

167 papers · 13.1k indexed · 2 hit papers · h-index 54

Impact in

Cell Biology top 0.2%
- Proteoglycans and glycosaminoglycans research
Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research

Papers in

Immunology and Allergy 27
- Cell Adhesion Molecules Research 27
Cell Biology 58
- Proteoglycans and glycosaminoglycans research 45

Co-authors: Jean Paul Thiery Peter Herrlich Helmut Ponta Wilko Thiele Christian Termeer Véronique Orian‐Rousseau Jan C. Simon Christina Fieber
Journals: Clinical & Experimental Metastasis (13 papers)Oncogene (10 papers)International Journal of Cancer (8 papers)PLoS ONE (6 papers)Journal of Cell Science (5 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Jonathan P. Sleeman

162 papers receiving 12.9k citations

Hit Papers

align trajectories log scale

Complex networks orchestrate epithelial–mesenchymal transitions 2006 · 3.3k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Nature Reviews Molecular Cell Biology
2002 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Jonathan P. Sleeman

Since Specialization

Citations

This map shows the geographic impact of Jonathan P. Sleeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan P. Sleeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan P. Sleeman more than expected).

Fields of papers citing papers by Jonathan P. Sleeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan P. Sleeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan P. Sleeman. The network helps show where Jonathan P. Sleeman may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan P. Sleeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan P. Sleeman Line = papers co-authored together Jonathan P. Sleeman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Novel, Cell-Compatible Hyaluronidase Activity Assay Identifies Dextran Sulfates and Other Sulfated Polymeric Hydrocarbons as Potent Inhibitors for CEMIP Cells ·Anja Schmaus, Sofia Spataro, Paul Sallmann, Stephanie Möller, Léonardo Scapozza, Marco Prunotto, Jonathan P. Sleeman	2025	1
2	Acellular Human Placenta Small-Diameter Vessels as a Favorable Source of Super-Microsurgical Vascular Replacements: A Proof of Concept Bioengineering ·Florian Falkner, S Mayer, Benjamin Thomas, Sarah Onon Zimmermann, Sonja Walter, Patrick Heimel, Wilko Thiele, Jonathan P. Sleeman, Amir K. Bigdeli, Herbert Kiss, Bruno K. Podesser, Ulrich Kneser, Helga Bergmeister, Karl H. Schneider	2023	5
3	Ketogenic diet does not promote triple-negative and luminal mammary tumor growth and metastasis in experimental mice Clinical & Experimental Metastasis ·Meret Grube, Arno Dimmler, Anja Schmaus, Rafael Saup, Tabea Wagner, Boyan K. Garvalov, Jonathan P. Sleeman, Wilko Thiele	2023	4
4	CEMIP (HYBID, KIAA1199): structure, function and expression in health and disease FEBS Journal ·Sofia Spataro, Concetta Guerra, Andrea Cavalli, Jacopo Sgrignani, Jonathan P. Sleeman, Lina Poulain, Andreas Boland, Léonardo Scapozza, Solange Moll, Marco Prunotto	2022	20
5	Quantitative Detection of Disseminated Melanoma Cells by Trp-1 Transcript Analysis Reveals Stochastic Distribution of Pulmonary Metastases Journal of Clinical Medicine ·Lenka Kyjacová, Rafael Saup, Melanie Rothley, Anja Schmaus, Tabea Wagner, Anja‐Katrin Bosserhoff, Boyan K. Garvalov, Wilko Thiele, Jonathan P. Sleeman	2021	2
6	BASIS: High-performance bioinformatics platform for processing of large-scale mass spectrometry imaging data in chemically augmented histology Scientific Reports ·Kirill Veselkov, Jonathan P. Sleeman, Emmanuelle Claude, Johannes P.C. Vissers, Dieter Galea, Anna Mróz, Ivan Laponogov, Mark Towers, Robert Tonge, Reza Mirnezami, Zoltán Takáts, Jeremy K. Nicholson, James Langridge	2018	33
7	TGFβ counteracts LYVE-1-mediated induction of lymphangiogenesis by small hyaluronan oligosaccharides Journal of Molecular Medicine ·Bauer Jochen, Melanie Rothley, Anja Schmaus, Luca Quagliata, Markus Ehret, Moritz Bosse Biskup, Véronique Orian‐Rousseau, David G. Jackson, Ronald J. Pettis, Alfred Harvey, Stefan Bräse, Wilko Thiele, Jonathan P. Sleeman	2017	23
8	Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes Oncotarget ·Cristina Cotarelo, Arno Schad, C. James Kirkpatrick, Jonathan P. Sleeman, Erik Springer, Marcus Schmidt, Sonja Thaler	2016	16
9	A Systematic Approach to Defining the microRNA Landscape in Metastasis Cancer Research ·Giridhar Mudduluru, Mohammed Abba, Jasmin Batliner, Nitin Patil, Maike Scharp, Taral R. Lunavat, Jörg H. Leupold, Olga Oleksiuk, Dilafruz Juraeva, Wilko Thiele, Melanie Rothley, Axel Benner, Yinon Ben‐Neriah, Jonathan P. Sleeman, Heike Allgayer	2015	50
10	Flow cytometry-based isolation of dermal lymphatic endothelial cells from newborn rats. PubMed ·Wilko Thiele, Melanie Rothley, Anja Schmaus, Diana Plaumann, Jonathan P. Sleeman	2014	4
11	The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer International Journal of Cancer ·Sonja Thaler, Gitta Thiede, Jan G. Hengstler, Arno Schad, Marcus Schmidt, Jonathan P. Sleeman	2014	27
12	The Disparate Twins: A Comparative Study of CXCR4 and CXCR7 in SDF-1α–Induced Gene Expression, Invasion and Chemosensitivity of Colon Cancer Clinical Cancer Research ·Doreen Heckmann, Patrick Maier, Stephanie Laufs, Li Li, Jonathan P. Sleeman, Marcus J. Trunk, Jörg H. Leupold, Frederik Wenz, W. Jens Zeller, Stefan Früehauf, Heike Allgayer	2013	44
13	Concepts of metastasis in flux: The stromal progression model Seminars in Cancer Biology ·Jonathan P. Sleeman, Gerhard Christofori, Riccardo Fodde, John G. Collard, Geert Berx, Charles Decraene, Curzio Rüegg	2012	70
14	Role of Fibulin-5 in Metastatic Organ Colonization Molecular Cancer Research ·Henrik Devitt Møller, Ulrik Ralfkjær, Natascha Cremers, Mika Frankel, Rune Troelsgaard Pedersen, Jörg Klingelhöfer, Hiromi Yanagisawa, Mariam Grigorian, Per Guldberg, Jonathan P. Sleeman, Eugene Lukanidin, Noona Ambartsumian	2011	23
15	ADAM10 Is the Constitutive Functional Sheddase of CD44 in Human Melanoma Cells Journal of Investigative Dermatology ·Ulf Anderegg, Thea Eichenberg, Tanja Parthaune, Christian Haiduk, Anja Saalbach, Linda Milkova, Andreas Ludwig, Jens Grosche, Marco Averbeck, Carl Gebhardt, Verena Voelcker, Jonathan P. Sleeman, Jan C. Simon	2008	68
16	CD24 Expression Causes the Acquisition of Multiple Cellular Properties Associated with Tumor Growth and Metastasis Cancer Research ·Petra Baumann, Natascha Cremers, Frans G. M. Kroese, Gertraud Orend, Ruth Chiquet‐Ehrismann, Toshi Uede, Hideo Yagita∥, Jonathan P. Sleeman	2005	279
17	Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2 European Journal of Biochemistry ·Vladimir Kirkin, Ralph Mazitschek, Jaya Krishnan, Anja Steffen, Johannes Waltenberger, Michael S. Pepper, Athanassios Giannis, Jonathan P. Sleeman	2001	2
18	Characterization of indolinones which preferentially inhibit VEGF‐C‐ and VEGF‐D‐induced activation of VEGFR‐3 rather than VEGFR‐2 European Journal of Biochemistry ·Vladimir Kirkin, Ralph Mazitschek, Jaya Krishnan, Anja Steffen, Johannes Waltenberger, Michael S. Pepper, Athanassios Giannis, Jonathan P. Sleeman	2001	88
19	Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro Oncogene ·Larry S. Sherman, Jonathan P. Sleeman, Robert F. Hennigan, Peter Herrlich, Nancy Ratner	1999	12
20	Variant Exons v6 and v7 Together Expand the Repertoire of Glycosaminoglycans Bound by CD44 Journal of Biological Chemistry ·Jonathan P. Sleeman, Kazuhiro Kondo, Jürgen Moll, Helmut Ponta, Peter Herrlich	1997	74

About Jonathan P. Sleeman

Jonathan P. Sleeman is a scholar working on Immunology and Allergy, Cell Biology, Oncology, Molecular Biology and Cancer Research, having authored 167 papers that have together received 13.1k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (45 papers), Glycosylation and Glycoproteins Research (38 papers), Lymphatic System and Diseases (28 papers), Cancer Cells and Metastasis (28 papers), Cell Adhesion Molecules Research (27 papers), Angiogenesis and VEGF in Cancer (24 papers), Immunotherapy and Immune Responses (15 papers) and Wnt/β-catenin signaling in development and cancer (9 papers). The work is most often cited by research in Cell Biology (3.1k citations), Immunology and Allergy (1.1k citations), Oncology (4.7k citations), Cancer Research (2.3k citations) and Molecular Biology (7.3k citations). Jonathan P. Sleeman has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Jean Paul Thiery, Peter Herrlich, Helmut Ponta, Wilko Thiele, Christian Termeer, Véronique Orian‐Rousseau, Jan C. Simon, Christina Fieber, Thomas Ahrens and Larry S. Sherman. Their work appears in journals such as Clinical & Experimental Metastasis, Oncogene, International Journal of Cancer, PLoS ONE and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact